• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    6/14/23 1:13:07 PM ET
    $AKU
    $AY
    $BENF
    $BIOC
    Medical Specialities
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $AKU alert in real time by email

     

    On Wednesday, 33 stocks hit new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was UnitedHealth Group (NYSE:UNH).
    • Biocept (NASDAQ:BIOC) was the smallest, in terms of market cap, to set a new 52-week low.
    • Tenon Medical (NASDAQ:TNON) shares traded down 51.96% to reach its 52-week low, making it the biggest loser.
    • Camber Energy (AMEX:CEI) shares actually gained 0.16%, rebounding after it reached its 52-week low.

    The stocks that set new 52-week lows on Wednesday:

    • UnitedHealth Group (NYSE:UNH) stock dropped to a yearly low on Wednesday of $445.83. Shares traded down 7.25%.
    • Atlantica Sustainable (NASDAQ:AY) stock drifted down 1.08% on Wednesday morning to hit a new 52-week low of $23.70.
    • Beneficient (NASDAQ:BENF) stock set a new 52-week low of $5.21 on Wednesday, moving down 7.19%.
    • PolyMet Mining (AMEX:PLM) shares hit a yearly low of $0.82. The stock was up 0.22% on the session.
    • Intevac (NASDAQ:IVAC) stock drifted down 13.84% on Wednesday morning to hit a new 52-week low of $3.68.
    • Precision BioSciences (NASDAQ:DTIL) shares hit a yearly low of $0.66. The stock was down 3.52% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 12.88% for the day.
    • FLJ Group (NASDAQ:FLJ) shares hit a yearly low of $0.28. The stock was down 13.73% on the session.
    • Great Elm Capital (NASDAQ:GECC) shares made a new 52-week low of $7.55 on Wednesday. The stock was down 3.5% for the day.
    • Passage Bio (NASDAQ:PASG) shares set a new 52-week low of $0.93. The stock traded down 0.75%.
    • IO Biotech (NASDAQ:IOBT) shares hit a yearly low of $1.58. The stock was down 19.66% on the session.
    • Upexi (NASDAQ:UPXI) shares set a new yearly low of $2.04 this morning. The stock was down 6.74% on the session.
    • Trio Petroleum (AMEX:TPET) stock hit $1.30 on Wednesday morning, setting a new 52-week low for a change of down 2.96%.
    • Akumin (NASDAQ:AKU) shares reached a new 52-week low of $0.33 on Wednesday morning, moving up 2.19%.
    • Castellum (AMEX:CTM) shares fell to $0.56 on Wednesday, setting a new 52-week low with a shift of down 4.72%.
    • Camber Energy (AMEX:CEI) stock hit a new 52-week low of $1.00. The stock was up 0.16% on the session.
    • iClick Interactive Asia (NASDAQ:ICLK) stock hit $2.05 on Wednesday morning, setting a new 52-week low for a change of down 4.66%.
    • Cineverse (NASDAQ:CNVS) stock hit $2.20 on Wednesday morning, setting a new 52-week low for a change of down 35.53%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.62 on Wednesday, setting a new 52-week low with a shift of down 17.84%.
    • Bluejay Diagnostics (NASDAQ:BJDX) stock hit a yearly low of $0.19. The stock was down 4.55% for the day.
    • OceanPal (NASDAQ:OP) shares reached a new 52-week low of $2.53 on Wednesday morning, moving down 7.66%.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new yearly low of $0.59 this morning. The stock was up 1.37% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a yearly low of $0.15. The stock was down 5.27% for the day.
    • Biocept (NASDAQ:BIOC) stock set a new 52-week low of $1.64 on Wednesday, moving down 2.58%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKU
    $AY
    $BENF
    $BIOC

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    4/7/2026$300.00Reduce → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    Passage Bio Inc.
    $PASG
    3/31/2026$30.00Outperform
    Oppenheimer
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    Passage Bio Inc.
    $PASG
    2/10/2026$21.00Buy
    Chardan Capital Markets
    IO Biotech Inc.
    $IOBT
    1/26/2026$0.50Overweight → Neutral
    Piper Sandler
    IO Biotech Inc.
    $IOBT
    1/8/2026$0.36Equal-Weight → Underweight
    Morgan Stanley
    UnitedHealth Group Incorporated
    $UNH
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $AKU
    $AY
    $BENF
    $BIOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guillermo del Toro's masterpiece Pan's Labyrinth Returns in 3D for 20th Anniversary from Cineverse and Fathom Entertainment on October 9

    Oscar® Winning Phenom Guillermo del Toro's Pan Labyrinth 20th Anniversary Will Return to the Big Screen both in 3D and 4K for the First TimeAlso Presented in 2D HDR VersionLOS ANGELES and DENVER, April 9, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), an entertainment technology company and studio, has announced that Fathom Entertainment, the leading specialty distributor of content to theatrical partners worldwide, will be the theatrical distribution partner for the re-release of Guillermo del Toro's master creation, Pan's Labyrinth.  Guillermo del Toro's Pan Labyrinth 20th Anniversary will be released in theaters nationwide on October 9, 2026. The announcement was made ahead of CinemaCon, a

    4/9/26 2:00:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference

    Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the Company will participate in the 25th Annual Needham Virtual Healthcare Conference being held April 13-16, 2026. 25th Annual Needham Virtual Healthcare Conference Format: Virtual Corporate presentation Date/Time: Tuesday, April 14, 2026 at 9:30am ET Webcast Link: Precision BioSciences Virtual Presentation Link If you are interested in meeting with the Precision team during the conference, please reach out to your Needham representative. A replay of the presentation wil

    4/8/26 7:01:00 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

    ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on rapid, near-patient testing, today announced the successful enrollment of 624 patients in its ongoing SYMON-II Trial, a pivotal clinical study evaluating the Company's Symphony™ platform for interleukin-6 (IL-6) testing in critical care settings to determine patient acuity for sepsis triage and monitoring. The SYMON-II study has a target enrollment of 750 patients, and the Company expects to complete enrollment within the next 2 to 3 months, subject to site activity and patient flow. Importantly, the study's inclusion and exclusion criteria hav

    4/7/26 6:30:00 AM ET
    $BJDX
    Medical/Dental Instruments
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    SEC Filings

    View All

    SEC Form 424B5 filed by Trio Petroleum Corp.

    424B5 - Trio Petroleum Corp (0001898766) (Filer)

    4/8/26 5:00:50 PM ET
    $TPET
    Oil & Gas Production
    Energy

    Trio Petroleum Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Trio Petroleum Corp (0001898766) (Filer)

    4/8/26 5:00:17 PM ET
    $TPET
    Oil & Gas Production
    Energy

    SEC Form DEFA14A filed by Precision BioSciences Inc.

    DEFA14A - PRECISION BIOSCIENCES INC (0001357874) (Filer)

    4/8/26 7:01:42 AM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ross Robin A.

    4 - Trio Petroleum Corp (0001898766) (Issuer)

    4/9/26 5:00:21 PM ET
    $TPET
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Hooper Michele J

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    4/6/26 5:04:51 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form 4 filed by Mcnabb Frederick William Iii

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    4/6/26 5:04:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CFO Lindsey Mark Wayne bought $70,000 worth of shares (35,000 units at $2.00), increasing direct ownership by 29% to 154,168 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:43 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chief Motion Pictures Officer Macias Yolanda sold $5,297 worth of shares (2,189 units at $2.42) and bought $60,000 worth of shares (30,000 units at $2.00), increasing direct ownership by 30% to 121,760 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:04 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AKU
    $AY
    $BENF
    $BIOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded UnitedHealth from Reduce to Hold and set a new price target of $300.00

    4/7/26 8:51:26 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth upgraded by Raymond James with a new price target

    Raymond James upgraded UnitedHealth from Mkt Perform to Outperform and set a new price target of $330.00

    4/1/26 8:15:26 AM ET
    $UNH
    Medical Specialities
    Health Care

    Oppenheimer initiated coverage on Passage BIO with a new price target

    Oppenheimer initiated coverage of Passage BIO with a rating of Outperform and set a new price target of $30.00

    3/31/26 8:17:27 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Leadership Updates

    Live Leadership Updates

    View All

    Beneficient Appoints Mack H. Hicks to Board of Directors

    DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

    3/12/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Efinix Appoints Cameron McAulay as Chief Financial Officer

    McAulay Brings a Decade of Public-Company Semiconductor CFO Experience to Support Efinix's Global Expansion Efinix, Inc., the FPGA pioneer accelerating edge AI innovation, today announced the appointment of Cameron McAulay as Chief Financial Officer and Senior Vice President Finance. McAulay brings more than 20 years of financial leadership experience in the semiconductor and technology industries, including over a decade of service as CFO at publicly traded companies, making him uniquely qualified to help guide Efinix through its next stage of growth and value creation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303081

    3/3/26 11:00:00 AM ET
    $IVAC
    $TGAN
    Industrial Machinery/Components
    Technology
    Semiconductors

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    $AKU
    $AY
    $BENF
    $BIOC
    Financials

    Live finance-specific insights

    View All

    Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026

    Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the fourth quarter 2025 and provide a business update on March 12, 2026. About Precision BioSciences, Inc. Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other gene editing technologies in the way it cuts, its smaller size, and its simpler structure. These features are intended for ARCUS nucleases

    3/9/26 4:15:00 PM ET
    $DTIL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2025 Financial Results and New Executive Chairman of Board

    Company to Host Conference Call and Webcast at 8:30 AM ET on March 3, 2026 Jason Reese Appointed as Executive Chairman of the Board of Directors, Succeeding Matthew Drapkin and Fortifying the Board's Management Oversight Mr. Drapkin Continues to Serve as Vice Chairman of Great Elm Group, Inc. - Remaining Engaged with GECC and Great Elm Capital Management, LLC, its Investment Adviser Platform Strengthened with Seasoned Credit Investor Chris Croteau Hired as Head of Research GECC's Investment Adviser Waives All Accrued Incentive Fees as of December 31, 2025, Equating to Approximately $2.3 Million, or $0.16 Per Share, and 1Q 2026 Incentive Fees Waived as Well GAAP NAV of $8.07 Per Share a

    3/2/26 5:47:04 PM ET
    $GECC
    $GEG
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Great Elm Capital Corp. ("GECC") Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    PALM BEACH GARDENS, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the "Company" or "GECC") (NASDAQ:GECC), a business development company, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, after the close of market trading on Monday, March 2, 2026. The results will be discussed in a conference call on Tuesday, March 3, 2026, at 8:30 a.m. ET. Date/Time:Tuesday, March 3, 2026 – 8:30 a.m. ET   Participant Dial-In Numbers: (United States):(877) 407-0789(International):(201) 689-8562   To access the call, please dial-in approximately five minutes before the start time and, when asked, provide the operator w

    2/27/26 4:22:51 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    $AKU
    $AY
    $BENF
    $BIOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Great Elm Capital Corp.

    SC 13D/A - Great Elm Capital Corp. (0001675033) (Subject)

    12/13/24 6:47:34 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Atlantica Sustainable Infrastructure plc

    SC 13D/A - Atlantica Sustainable Infrastructure plc (0001601072) (Subject)

    12/12/24 12:30:42 PM ET
    $AY
    Electric Utilities: Central
    Utilities

    SEC Form SC 13G filed by Great Elm Capital Corp.

    SC 13G - Great Elm Capital Corp. (0001675033) (Subject)

    12/12/24 8:44:54 AM ET
    $GECC
    Finance: Consumer Services
    Finance